Haylee Kurkoski, PA-C | |
164 Summit Ave # C70, Providence, RI 02906-2853 | |
(401) 793-4545 | |
(401) 793-7866 |
Full Name | Haylee Kurkoski |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 164 Summit Ave # C70, Providence, Rhode Island |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033776398 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363AS0400X | Physician Assistant - Surgical | (Connecticut) | Secondary |
363AS0400X | Physician Assistant - Surgical | PA01313 (Rhode Island) | Primary |
Mailing Address | Practice Location Address |
---|---|
Haylee Kurkoski, PA-C Po Box 16149, Rumford, RI 02916-0697 Ph: (401) 453-9625 | Haylee Kurkoski, PA-C 164 Summit Ave # C70, Providence, RI 02906-2853 Ph: (401) 793-4545 |
News Archive
The North American Center for Continuing Medical Education, LLC , in partnership with HMP Communications, LLC, publisher of EP Lab Digest, today announced several key sessions on the treatment of atrial fibrillation at the upcoming Electrophysiology Innovations Congress EP Innovations 2010, the world's premier annual electrophysiology meeting, to be held December 9-11, 2010, at the Washington Hilton in Washington, DC.
Time course analyses of neuronal cell death and its underlying mechanisms require laborious experiments and multiple endpoint assays, often involving labelling with irritating compounds and cell disruption. A recent study used the xCELLigence System of Roche to investigate the response of the neuronal-like cell line HT-22 and cultured primary rat cortical neurons to different cell death stimuli and neuroprotectants.
Elorac, Inc., a rapidly growing specialty pharmaceutical company focused on the treatment of dermatological disorders announced that it has been granted Orphan Drug Designation by the U.S. Food and Drug Administration for its naloxone lotion for the topical treatment of pruritus accompanying cutaneous t-cell lymphoma (CTCL, also known as mycosis fungoides).
Two existing chemotherapy drugs appear to be a powerful pair in targeting errant stem cells that are making breast cancer and enabling its spread and recurrence, scientists report.
› Verified 3 days ago
Miss Celia Cordeiro, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 450 Brook St, Providence, RI 02906 Phone: 401-863-3953 | |
Kelsey Heck, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 593 Eddy St., Claverick 2, Providence, RI 02903 Phone: 401-444-4000 | |
Bret Caulfield, Physician Assistant Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-4000 | |
Ms. Karen Lynn Steinmetz, PA Physician Assistant Medicare: May Accept Medicare Assignments Practice Location: 593 Eddy St, Suite 814, Providence, RI 02903 Phone: 401-444-5891 Fax: 401-444-8158 | |
Linhuang Han, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 593 Eddy St, Main 4, Providence, RI 02903 Phone: 401-444-7085 | |
Elizabeth Mewha, PAC Physician Assistant Medicare: Medicare Enrolled Practice Location: 593 Eddy Street, Claverick 2, Providence, RI 02903 Phone: 401-444-5451 Fax: 401-444-5922 | |
Mr. Mark James Nash, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 208 Collyer St, Providence, RI 02904 Phone: 401-793-2354 Fax: 401-793-7624 |